Approved Study Database

Ref. No. Scientific Title Principal investigator
2005.418 A Randomized Double-Blind Phase-2 Study of Anastrozole Plus Lonafarnib (SCH 66336) or Anastrozole Plus Placebo for the Treatment of Subjects With Advanced Breast Cancer Prof. Yeo Winnie
2002.152 A Randomized Double-Blind Placebo-Controlled Study of The Effect Of Danggui Preparation On Menopausal Symptoms And Quality Of Life In Hong Kong Chinese Women Prof. Haines Christopher John
2004.134 A Randomized Double-blind Placebo-controlled Study to Assess the Prevention of Low-dose Acetylsalicylic Acid (ASA) Associated Gastroduodenal Lesions and Upper Gastrointestinal Symptoms in Patients Taking Esomeprazole 20 mg Once Daily (od) for 26 Weeks Prof. Chan Ka Leung Francis
2004.035 A Randomized Double-Blind Placebo-Controlled Trial of Prophylactic Antibiotics in Preventing Female Urinary Tract Infection After Urodynamic Study Prof. Yip Shing Kai
2020.080 A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease Prof. YAN Bryan Ping Yen
甄秉言教授
2011.339 A randomized double-blinded, controlled evaluation of the effectiveness of iv PCA morphine in patients receiving intercostal nerve blocks after video-assisted thoracosopic procedure. Is PCA morphine necessary in addition to intercostals nerve block for Vi Dr Lam Kit Ying
2021.497 A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients with Dedifferentiated Liposarcoma Dr. LOONG Herbert Ho Fung
龍浩鋒
2022.413 A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer Prof. MA Brigette Buig Yue
馬碧如
2023.583 A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma Prof. NG Chi Fai
2021.640 A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Subjects with Metastatic or Locally Advanced Unresectable Urothelial Cancer Dr. WONG Kenneth Chun Wai
王俊威
2015.507 A Randomized Open-Label Phase III Study of Single Agent Pembrolizumab versus Single Agent Chemotherapy per Physician’s Choice for Metastatic Triple Negative Breast Cancer (mTNBC) – (KEYNOTE-119) Prof. YEO Winnie
楊明明
2016.551 A Randomized Open-label Study to Evaluate the Efficacy and Safety of Tacrolimus and Corticosteroids in Comparison with Mycophenolate Mofetil and Corticosteroids in Subjects with Class III/IV±V Lupus Nephritis Prof. TAM Lai Shan
譚麗珊
2012.279 A randomized parallel group single blinded study of effects of Dayan (Wild Goose) Qigong on type 2 diabetes patients with low cardiovascular risk. Dr. Tsang Chiu-Chi
2016.506 A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Prof. LEE Alex Pui Wai
李沛威教授
2008.229 A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed Alone, and Erlotinib Alone, As Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Professor Mok Tony S. K.
2014.404 A Randomized Phase 2 Study of LY2157299 versus LY2157299 – Sorafenib Combination versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma Prof. CHAN Stephen Lam
2007.471 A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer Dr. HO Wing Ming
2009.024 A Randomized Phase 2 Trial of PF-00299804 versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen Prof. Mok TONY S.K.
2020.025 A Randomized Phase 3 Multicenter Open-label Study to Compare the Efficacy of TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy in Patients With Non–Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Prof. MOK Tony
莫樹錦教授
2011.179 A Randomized Phase 3 Study Comparing First-Line Pemetrexed plus Cisplatin (Followed by Gefitinib as Maintenance) with Gefitinib Monotherapy in East Asian (Never Smoker or Light Ex-Smoker) Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Prof. Mok Tony Shu Kam
2022.654 A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07) Dr. LOONG Herbert Ho Fung
2021.631 A Randomized Phase 3 Study of MRTX849 versus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation Prof. MOK Tony Shu Kam
莫樹錦
2010.602 A Randomized Phase 4 Study Comparing 2 Intravenous Temsirolimus (TEMSR) Regimens in Subjects With Relapsed, Refractory Mantle Cell Lymphoma Dr. LEI Kenny Ieng Kit
2008.479 A Randomized Phase I/II, Multi-Center, Open-Label Trial of PR104 and Sorafenib in Patients with Advanced Hepatocellular Carcinoma Dr. Chan Stephen Lam
2009.248 A randomized phase II study comparing acupuncture to acupuncture with moxibustion on reduction of chemotherapy-induced neutropenia Professor Mok Tony
2002.050 A Randomized Phase II Study of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Chemotherapy Using Taxotere and Cisplatin in Advanced Nasopharyngeal Carcinoma Prof. Chan Tak Cheung Anthony
2004.031 A Randomized Phase II Study to Evaluate the Effect of CKBM-T01 Vs Tamoxifen on Quality of Life (QOL) of Patients with Inoperable Hepatocellular Carcinoma (HCC) Prof. Mok Tony
2004.179 A Randomized Phase II Study to Investigate the Effects of Recombinant Intestinal Trefoil Factor (ITF) on Oral Mucositis in Nasopharyngeal Cancer (NPC) Patients Receiving Radiation Therapy Prof. Leung Sing Fai
2010.564 A Randomized Phase III study of Oxaliplatin (Eloxatin) and Capecitabine on top of Sorafenib versus Sorafenib alone as first-line palliative treatment in advanced hepatocellular carcinoma patients ineligible for curative resection or local treatment Prof Chan Lam
2009.386 A randomized phase III, double-blind, placebo-controlled multicenter trial of Everolimus in combination with Trastuzumab and Paclitaxel, as first line therapy in women with HER2 positive locally advanced or metastatic breast cancer Dr. HO Wing Ming
2008.342 A Randomized Placebo Controlled Trial of Alternative Herbal Medicine (Danshen/Gegen) in the Prevention of Atherosclerosis in Postmenopausal Women with Hypercholesterolemia Prof. Kwok Timothy
2011.207 A randomized placebo controlled trial of homocysteine lowering to prevent dementia in older patients with mild cognitive impairment and high plasma homocysteine Prof Kwok Timothy
2009.183 A randomized placebo controlled trial of low dose angiotensin converting enzyme inhibitor to prevent pneumonia in older people who require tube feeding because of neurological dysphagia Prof Kwok Timothy
2001.429 A Randomized Placebo Controlled Trial of Traditional Chinese Medicine in the Treatment of Irritable Bowel Syndrome Prof. Leung Wai Keung
2007.092 A Randomized Placebo Controlled Trial of Vitamin B12 Supplementation to Prevent Cognitive Decline in Older Women with Vitamin B12 Deficiency Prof. Kwok Timothy
2016.617 A randomized placebo controlled trial on effect of modified Traditional Chinese Medicine (TCM) formula Wuzi Yanzong Pill (WYP, 五子衍宗丸) on improving semen qualities in men with sub-optimal parameters Dr. CHUNG Jacqueline Pui Wah
2019.142 A Randomized Placebo-Controlled Clinical Trial of an Innovative Herbal Formula for Atopic Dermatitis in Children: Evaluations of Modified Qing-Ying Decoction on Efficacy and Gut Microbiome Prof. LIN Zhixiu
2022.423 A Randomized Placebo-Controlled Pilot Study of an Herbal Formula Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children Prof. LIN Zhixiu
林志秀
2020.676 A randomized placebo-controlled trial for adjunctive bright light therapy in patients with bipolar depression and eveningness Dr. CHAN Joey Wing Yan
陳詠欣
2007.468 A Randomized Placebo-Controlled Trial of Acupuncture in the Treatment of Irritable Bowel Syndrome: Clinical and Functional MRI Evaluation Prof Chu Chiu Wing, Winnie
2008.047 A Randomized Prospective Study of Colle Doctor Tang Ning
2018.270 A randomized study of neoadjuvant chemoradiotherapy with or without intensification with the FOLFOXIRI chemo-regimen for high-risk locally advanced rectal cancer Prof. MA Brigette
馬碧如
2009.176 A randomized study of prolonged pretreatment with gonadotrophin releasing hormone agonist (GnRHa) prior to frozen-thawed embryo transfer (FET) cycles in patients with endometriosis Dr. Lok Ingrid Hung
2009.177 A randomized study of prolonged pretreatment with gonadotrophin releasing hormone agonist (GnRHa) prior to frozen-thawed embryo transfer (FET) cycles in patients with repeated implantation failure Dr. Lam P.M. Emily
2013.599 A randomized study of surgical intervention for childhood obstructive sleep apnoea – cardiovascular perspective Prof. LI Albert Martin Man Chim
2010.493 A randomized study of surgical intervention for mild childhood obstructive sleep apnoea – neurocognitive perspective Prof. LI Albert Martin Man Chim
2016.013 A Randomized Study to Determine the Efficacy and Tolerability of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese breast cancer patients. Prof. YEO Winnie
楊明明
2008.546 A Randomized Study to Evaluate the Efficacy and Mechanism of Transcutaneous Electrical Nerve Stimulation on Acupoints (Acu-TENS) in Reducing Discomfort Associated with Barostat-induced Rectal Distension Dr. Ng Simon Siu-Man
2016.071 A randomized study to investigate the effect of focal zone size on treatment outcomes in patients undergoing extracorporeal shockwave lithotripsy to renal calculi Prof. NG Chi Fai
吳志輝
2020.155 A randomized trial of alendronate to slow brain atrophy in older people with mild cognitive impairment and osteopenia Dr. KWOK Timothy Chi Yui
郭志銳

Page 36 of 254.